UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040748
Receipt number R000046520
Scientific Title Treatment Options of Adolescent Gestational Diabetes: Effect on Outcome
Date of disclosure of the study information 2020/06/13
Last modified on 2022/12/15 12:21:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Adolescent Gestational Diabetes outcomes

Acronym

AGDO

Scientific Title

Treatment Options of Adolescent Gestational Diabetes: Effect on Outcome

Scientific Title:Acronym

TOAGDEO

Region

Asia(except Japan)


Condition

Condition

Adolescent pregnant ladies

Classification by specialty

Endocrinology and Metabolism Obstetrics and Gynecology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate effects of different management plans of gestational diabetes in teenagers including insulin, metformin (as an oral anti-diabetic agent), and lifestyle without pharmacological treatment.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Maternal glycemic control

Key secondary outcomes

Preeclampsia, gestational length, delivery mode.
Neonatal outcomes including: preterm birth, large or small for gestational age, macrosomia, delivery weight, hypoglycemia, Apgar score, and admission to NICU.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

metforim

Interventions/Control_2

diet

Interventions/Control_3

insulin

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit

19 years-old >=

Gender

Female

Key inclusion criteria

adolescent pregnant mothers
singletone
has the diagnosis of gestational diabetes

Key exclusion criteria

chronic illness like diabetes before pregnancy

Target sample size

61


Research contact person

Name of lead principal investigator

1st name Shaymaa
Middle name Kadhim
Last name Jasim

Organization

University of Baghdad

Division name

College of Medicine

Zip code

00964

Address

Bab Al-Moaddam, Baghdad, Iraq.

TEL

009647811284170

Email

shaimaa79kadhim@gmail.com


Public contact

Name of contact person

1st name Hayder
Middle name
Last name Al-Momen

Organization

University of Baghdad

Division name

Al-Kindy College of Medicine

Zip code

00964

Address

Al-Nahda square, baghdad, Iraq.

TEL

009647811284169

Homepage URL


Email

hayder77almusawi@gmail.com


Sponsor or person

Institute

University of Baghdad

Department of Obstetrics and Gynecology

Institute

Department

Personal name



Funding Source

Organization

university of Baghdad

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Baghdad

Address

Bab Al-Moaddam, Baghdad, Iraq.

Tel

009647727289433

Email

sarmarsarmar@yahoo.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Medical City Hospital in Baghdad


Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 13 Day


Related information

URL releasing protocol

https://data.mendeley.com/datasets/3jgzvk58sy/1

Publication of results

Unpublished


Result

URL related to results and publications

https://data.mendeley.com/datasets/3jgzvk58sy/1

Number of participants that the trial has enrolled

61

Results

Metformin is the best option

Results date posted

2020 Year 06 Month 13 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Matched adolescent pregnant mothers

Participant flow

Metformin group= 19
Insulin group= 17
Lifestyle group= 11

Adverse events

obstetrical and neonatal events were more in insulin group.

Outcome measures

Glycemic control was the least in insulin group.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 04 Month 05 Day

Date of IRB

2016 Year 05 Month 02 Day

Anticipated trial start date

2016 Year 06 Month 01 Day

Last follow-up date

2019 Year 05 Month 25 Day

Date of closure to data entry

2019 Year 05 Month 31 Day

Date trial data considered complete

2020 Year 03 Month 06 Day

Date analysis concluded

2020 Year 04 Month 09 Day


Other

Other related information



Management information

Registered date

2020 Year 06 Month 13 Day

Last modified on

2022 Year 12 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046520


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name